Skip to content
Education Training, Medical Health Aged Care

New Program from Doctors For Nutrition Aims to Transform Diabetes Care for Doctors and Patients

Doctors For Nutrition 2 mins read

The problem:

Diabetes is a rapidly growing global health challenge, affecting 589 million adults—around 1 in 9 people—with numbers projected to rise by 45% to 853 million by 2050. In Australia alone, more than 1.3 million people are living with diabetes, with a new diagnosis every five minutes, making it the country’s fastest-growing chronic condition. The burden is disproportionately higher among Aboriginal and Torres Strait Islander peoples, who face significantly greater risks of developing, being hospitalised for, and dying from type 2 diabetes.

Many health professionals report limited training and low confidence in providing structured nutrition and lifestyle counselling for type 2 diabetes risk reduction. Our new course has been designed to help close that gap.

The solution:

Doctors For Nutrition, an independent not-for-profit committed to evidence-based education, announces ‘Overcoming Diabetes in Clinical Practice’— an on‑demand, RACGP and ACRRM–approved activity designed for GPs and primary care clinicians who want practical, evidence-based strategies to help patients prevent, manage, and in many cases reverse type 2 diabetes using nutrition and other lifestyle interventions, alongside appropriate pharmacotherapy.

Overcoming Diabetes at a glance:

Developed by Australian doctors and health experts, Overcoming Diabetes in Clinical Practice is a fully-referenced, fact-based and accessible on-demand program that covers:

  • Clear explanations of how diet and lifestyle impact health and diabetes risk

  • Practical guidance, recipes, and resources to support change

  • Evidence-based information for doctors treating patients living with type 2 diabetes, at risk, or wanting to protect their health long-term

“Type 2 diabetes affects thousands of Australian families every year, but there is hope—prevention and reversal are possible,” said Rebecca Stonor, DFN CEO. “This course empowers doctors and medical professionals to help their patients take charge of their health, by focussing on the underlying causes of type 2 diabetes— all backed by the latest nutrition science.”

There is also a ‘patient-focused’ program that is an excellent resource for the medical community to recommend to their patients and is a trusted companion for clinical care. Overcoming Diabetes, has been developed as an on-demand course for anyone living with—or looking to prevent—type 2 diabetes.  

Access the two courses:

 


About us:

Doctors For Nutrition is an independent, registered charity founded in 2018 with the mission to inspire the healthcare sector, policymakers, and society at large to integrate whole food plant-based nutrition and other lifestyle medicine principles as powerful tools for disease prevention and care. With a team of medical and dietetic practitioners across Australia, New Zealand, and globally, Doctors For Nutrition works to equip clinicians, institutions, and communities with evidence-based education and resources on optimal human nutrition-led lifestyle medicine strategies to prevent, alleviate, and even reverse chronic diseases, aiming to create a world free from preventable disease where everyone can thrive and live to their full potential.


Contact details:

Rebecca Stonor, CEO
Doctors For Nutrition
[email protected]
0413309944

Media

More from this category

  • Education Training
  • 30/08/2026
  • 15:58
National Courses

National Courses reveals the top courses that can turbo-charge a career

Australians looking to get their foot in the door, change industries or make themselves more competitive in the job market are increasingly turning to…

  • Contains:
  • Government Federal, Medical Health Aged Care
  • 30/08/2026
  • 07:00
Ethical Strategies on behalf of MSD Australia & New Zealand

Government funds medicine for approximately 10,000 eligible Australians with certain advanced or metastatic cancers

Cancer patients, advocates, and doctors are joining MSD in welcoming a milestone decision by the Federal Government to provide subsidised access to KEYTRUDA® (pembrolizumab) for over 10,000 newly eligible Australians over the next four years, with certain advanced and metastatic cancers.1 From 1 September 2026, the cost of KEYTRUDA will be subsidised through the Pharmaceutical Benefits Scheme (PBS) for eligible Australians whose cancer cannot be surgically removed and is known to be sensitive to immunotherapy.1 This means eligible patients, including those with rare or less common cancers with limited treatment options, will pay just $7.70 (concession) or $25.00 (general patients)…

  • Medical Health Aged Care
  • 29/08/2026
  • 08:52
Takeda Pharmaceutical Company Limited

Takeda Receives U.S. FDA Approval of MIMRYLO(TM) (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera

MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV) MIMRYLO…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.